drugset
drugset / Trial / NCT06023706

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

NCT06023706 ↗

Phase 3 Recruiting 188 enrolled Nantes University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.

Timeline

Start
2023-11-08
Primary completion
2027-01-08
Completion
2027-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 179 mg Topical

Indications

coccygodynia neuropathy, painful